MechanismsHumans23 participantsCohort study

Frailty of older patients is not reflected in the melanoma tumor microenvironment and treatment response to immune checkpoint blockade therapy

Figure 1. Frailty status does not associate with survival or tumor immune composition in patients with melanoma.
Open the figure at full size
Figure 1. Frailty status does not associate with survival or tumor immune composition in patients with melanoma.Frailty status does not associate with survival or tumor immune composition in patients with melanoma.Özkan et al.

Journal for Immunotherapy of Cancer

The paper

Leiden University Medical Center · Helse Førde

Journal for Immunotherapy of Cancer · 18 Sep 2026

doi.org/10.1136/jitc-2026-015212PubMed 42759983

More on Immune response